Roche Hit by Failure of Cancer Drug Trial

Roche said a late-stage study of its breast cancer drug Kadcyla failed to yield superior results to an existing treatment, damaging the outlook for stronger sales in one of its key drug markets.



from WSJ.com: US Business http://ift.tt/1C7s0GE

via IFTTT